πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 160 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8748621

1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

Addex Pharma, S.A. Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722894

1,3-disubstituted-4-phenyl-1H-pyridin-2-ones

Addex Pharma, S.A. Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716480

7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modu

Addex Pharma, S.A. Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8712696

Methods of prognosing a rheumatoid arthritis remission phenotype

PROGENIKA BIOPHARMA, S.A. Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697744

Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric m

Addex Pharma, S.A. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697689

Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691852

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Amirall, S.A. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691849

3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691813

Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8674106

Alkynyl derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8604033

Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteri

Addex Pharma, S.A. Β· Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563731

Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hyd

Almirall, S.A. Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536165

Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Almirall, S.A. Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524908

Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethy

Almirall, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524726

Amido derivatives and their use as positive allosteric modulators of metabotropic glutamat

Addex Pharma, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524718

Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic

Addex Pharma, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8519002

Colchicine solid complex; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8513252

Pyrazole derivatives and their use as positive allosteric modulators of metabotropic gluta

Addex Pharma, S.A. Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501943

Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid a

Almirall, S.A. Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8497290

Thiocolchicine derivatives, method of making and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8461187

Multiple PPI dosage form

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450341

Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibi

Almirall, S.A. Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445541

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted